Publication date: December 2026 Source: Molecular Metabolism, Volume 114 Author(s): Vasilios Drakopoulos, Xiaolong Feng, Daria J. Paulis, Abigail C. Wust, Lotus S. Jeffs, Romana Stark, Greg J. Stuart, Claire J. Foldi, Alex Reichenbach, Zane B. Andrews
A cortico-hypothalamic circuit regulates metabolism and stress resilience in a sex-specific manner. // Molecular Metabolism. – URL: https://www.sciencedirect.com/science/article/pii/S2212877826001432?dgcid=rss_sd_all
A cortico-hypothalamic circuit regulates metabolism and stress resilience in a sex-specific manner. Molecular Metabolism. https://www.sciencedirect.com/science/article/pii/S2212877826001432?dgcid=rss_sd_all
“A cortico-hypothalamic circuit regulates metabolism and stress resilience in a sex-specific manner.” Molecular Metabolism.
@article{article59161,
title = {A cortico-hypothalamic circuit regulates metabolism and stress resilience in a sex-specific manner},
journal = {Molecular Metabolism},
url = {https://www.sciencedirect.com/science/article/pii/S2212877826001432?dgcid=rss_sd_all}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials